Search All Resources
Common Drug-Drug Interactions with HCV DAAs | June 22, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #drug interactions #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this presentation, Bradley Moran, PharmD, shares a valuable overview of common medication interactions with hepatitis C medications.
Date added: 06/22/22
HCV 101 | June 2, 2022
Type: Training
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this training, Dr. Jorge Mera and Whitney Essex discuss screening, treatment and management of patients with hepatitis C at the primary care level through didactic and case presentations, recommendations, and provides an opportunity to become part of a learning ...
Date added: 06/2/22
Indian Country ECHO Treatment Recommendation Analysis | April 27, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this presentation, Ashley Wirth, MD/MCR candidate, discusses "Results from an Analysis of Indian Country HCV ECHO Case Forms and Treatment Recommendations" from years 2017-2021. In her presentation she highlights; determining how many patients received treatment recommendations for HCV treatment ...
Date added: 04/27/22
Loved Here, Safe Here Campaign Materials
Type: Handouts
Audience: Clinical Community
Program: Infectious Disease ECHO Program Trans & Gender Affirming Care ECHO Program HIV ECHO Program Hepatitis C
Keywords: #2slgbtq #std testing
The creation of safe, inclusive, and welcoming spaces is critically important to provide holistic wellness for 2SLGBTQ (Two Spirit, lesbian, gay, bisexual, transgender, and queer/questioning) community members. A safe space is a place, program, or community that is intentionally working ...
Date added: 04/12/22
MAT and the HCV Provider | March 23, 2022
Type: Past Presentation
Program: Hepatitis C
Keywords: #harm reduction #hcv treatment #mat #OUD #SUD
In this presentation Dr. Jessica Gregg provides an overview of screening, treatment options, and individualized care for patients with substance use disorder and hepatitis C virus. The trifecta of interventions needed include treating the HCV infection with antivirals, decreasing the ...
Date added: 03/23/22
Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cure #hcc #hepatocellular carcinoma #svr
In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after achieving cure from hepatitis C virus.
Date added: 02/22/22
Fentanyl’s Rising Presence in Oregon | October 27, 2021
In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed to risks of fentanyl, and highlight how we may better ...
Date added: 10/27/21
Managing Symptoms During Hepatitis C Treatment (ANTHC)
Guidance on how to manage many of the common symptoms during hepatitis C treatment.
Date added: 10/20/21
Living with Liver Disease (ANTHC)
Type: Website
Audience: Community
Program: Hepatitis C Infectious Disease ECHO Program
Keywords: #liver disease
Resources for patients with Hepatis B, C, or other liver diseases.
Date added: 10/20/21
Practice Guidelines (AALSD)
Type: Website
Audience: Clinical
Program: Hepatitis C Infectious Disease ECHO Program
Keywords: #hepatology #liver disease
American Association for the Study of Liver Diseases practice guidelines which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Date added: 10/19/21